The crosstalk between leptin signaling and other inflammatory cytokines could explain why patients do not exhibit increased appetite or lower energy expenditure, despite decreased levels of leptin in many disease-associated cachexic states such cancer, COPD, and aging. This evidence concerns the gene LEP and cancer.